Dr. Debra Faulk is an associate professor of pediatric anesthesiology and board-certified pediatric anesthesiologist. Her interests include sedation, simulation, pre-operative anxiety, and emergence agitation in kids. Dr. Faulk’s current research is in the monitoring of neuromuscular blockade in pediatric anesthesia, including studies looking a residual neuromuscular blockade as well as validation of objective EMG monitoring and their use for appropriate dosing of sugammadex in children.

Ross Renew, MD, FASA, FASE, graduated from Clemson University (Chemistry, BS) and completed medical school at the University of South Carolina School of Medicine. Dr. Renew completed anesthesia residency at Mayo Clinic Florida and his fellowship in adult cardiothoracic anesthesiology at Mayo Clinic in Rochester, MN. Dr. Renew then returned to Jacksonville and has worked on staff at Mayo Clinic Florida, where he is currently an Associate Professor of Anesthesiology. Dr. Renew serves as the Vice Chair of Research and Associate Program Director for the department’s residency program.  His research interests involve neuromuscular blockade and monitoring, transesophageal echocardiography, and caring for the cardiac patient undergoing non-cardiac surgery.

Dr. Alanna A. Morris is an Associate Professor of Medicine in the Division of Cardiology at Emory University School of Medicine and the Emory Cardiovascular Clinical Research Institute. Currently she serves as the Director for Heart Failure Research and the Associate Program Director for the Clinical Investigator Track of the Cardiology Fellowship. Dr. Morris received her undergraduate degree in Biology from Xavier University of Louisiana, and her medical degree from the Harvard Medical School. She completed her residency at Brigham and Women’s Hospital in Boston, Massachusetts. Subsequently, she came to Emory University to complete fellowships in general cardiology, and advanced heart failure, and transplant. Her clinical time is spent as faculty in Emory’s Center for Heart Failure Therapy and Transplantation. She has held K23 funding from the NIH/NHLBI, and career development award funding from the Robert Wood Johnson Foundation Harold Amos Faculty Development Program. Her research program focuses on studying mechanisms that underlie race- and gender disparities in heart failure risk and progression, including the role of biologic determinants such as biomarkers of oxidative stress and endothelial dysfunction, as well as social determinants of health including neighborhood that amplify risk for adverse outcomes in heart failure.

Javed Butler, MD, MPH, MBA, is the Patrick H. Lehan Chair in Cardiovascular Research, and Professor and Chairman of the Department of Medicine at the University of Mississippi Medical Center in Jackson, Mississippi. He is also a Professor of Physiology. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the director for heart failure research at Emory University and director of the heart and heart-lung transplant programs at Vanderbilt University prior to that.

He received his medical degree from the Aga Khan University and then completed residency training at Yale University, cardiology fellowship, and advanced heart failure, and transplant fellowships at Vanderbilt University, and cardiac imaging fellowship at the Massachusetts General Hospital at the Harvard Medical School. He received his Master of Public Health Degree from Harvard University and Masters in Business Administration from Emory University.

Dr. Butler is board certified in cardiovascular medicine, advanced heart failure, and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, U.S. Food & Drug Administration, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Dr. Butler has authored more than 700 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals. He has been cited numerous times in America’s Best Doctors list.

Jessica Isom, MD, MPH, is a board-certified community psychiatrist and faculty leader in the Yale Department of Psychiatry’s Social Justice and Health Equity Curriculum. She primarily works in Boston as an attending psychiatrist at Codman Square Health Center where she is leading a grant effort to infuse antiracism in OUD services. She is a nationally recognized expert on racial equity and justice in psychiatry with a focus on workforce development and organizational transformation. Her professional interests include working toward eradicating racial and ethnic mental health disparities, mitigating the impact of implicit racial bias on clinical care, and the use of a community-centered population health approach in psychiatric practice. She serves on multiple advisory boards and is a consultant, curriculum developer, and presenter to a variety of organizations including Fortune 500 companies and medical societies through her company, Vision for Equity LLC.

Amanda J. Calhoun, MD, MPH, is an Adult/Child Psychiatry Resident at Yale Child Study Center/Yale School of Medicine and is concurrently pursuing a PhD in Yale’s Graduate School of Arts & Sciences.  Dr. Calhoun graduated from Yale University with a BA in Spanish and received her MD/MPH from Saint Louis University School of Medicine, in St. Louis, Missouri, where she grew up.  Dr. Calhoun’s research, which focuses on the mental health effects of anti-Black racism on children, has been funded by multiple national awards.  Dr. Calhoun also specializes in the effects of medical racism and writes for both academic journals as well as general press and has published in New England Journal of Medicine, TIME magazine, HuffPost, STAT News, Washington Post, BET News, and many others. Dr. Calhoun is also a public speaker, and a consultant and has made multiple national news appearances, most recently on CBS News discussing the rising rates of Black youth suicide.

Twitter handle: @AmandaJoyMD

Professional Instagram: amandajoymd

Joia A. Crear-Perry, MD, FACOG, is a physician, policy expert, thought leader, and advocate for transformational justice. As the founder and president of the National Birth Equity Collaborative (NBEC), she identifies and challenges racism as a root cause of health inequities.

She is a highly sought-after trainer and speaker who has been featured in national and international publications including Essence and Ms. Magazine. In 2020, Dr. Crear-Perry was honored by USA Today in its “Women of the Century” series and featured on ABC Nightline’s “Hear Her Voice”.

Dr. Crear-Perry has twice addressed the United Nations’ Office of the High Commissioner for Human Rights to elevate the cause of gender diversity and urge a human rights framework toward addressing maternal mortality. A proud recipient of both the Congressional Black Caucus Healthcare Heroes award and the Maternal Health Task Force at Harvard University Global Visionary Award for Commitment to Advancing Women’s Health, Dr. Crear-Perry’s most notable efforts include the removal of race as a risk factor for illnesses including premature birth.

Previously, she served as the Executive Director of the Birthing Project, Director of Women?s and Children’s Services at Jefferson Community Healthcare Center, and as the Director of Clinical Services for the City of New Orleans Health Department. In that role, she was responsible for four facilities that provided health care for the homeless, pediatric, WIC, and gynecologic services within the New Orleans clinical service area. Dr. Crear-Perry has been celebrated for her work improving the availability and utilization of affordable health care for New Orleans citizens post the Hurricane Katrina disaster of 2005.

Dr. Crear-Perry testified before the House Energy and Commerce Committee as the Democratic witness in support of the only Maternal Health Bill signed into law under the Trump administration. She has received funding from the Robert Wood Johnson Foundation (RWJF) to work with the American College of Obstetrics and Gynecology (ACOG) and develop a Standard for Respectful Maternity Care. She also serves on the National Quality Forum Maternal Mortality and Morbidity Committee and the Joint Commission Perinatal Safety Project Technical Advisory Panel.

Dr. Crear-Perry currently serves as a Principal at Health Equity Cypher and on the Board of Trustees for Black Mamas Matter Alliance, Community Catalyst, National Clinical Training Center for Family Planning, and the UCSF PTBi.

After completing undergraduate studies at Princeton University and Xavier University, Dr. Crear-Perry received her MD from Louisiana State University and completed her residency in Obstetrics and Gynecology at Tulane University’s School of Medicine. She was also recognized as a Fellow of the American College of Obstetrics and Gynecology.

She is married to Dr. Andre Perry and has three children: Jade, Carlos, and Robeson. Her love is her family; health equity is her passion; maternal and child health are her callings.

Sophie M. Balzora MD, FACG, is a Clinical Associate Professor at the NYU Grossman School of Medicine. Dr. Balzora has focused her academic efforts on improving physician engagement and enhancing the patient experience through objective structured clinical exams (OSCEs). She is Vice Chair of the American College of Gastroenterology (ACG) Diversity, Equity, and Inclusion Committee; Co-founder of ACG’s #DiversityinGI Social Media Campaign; and former Chair of the ACG Public Relations Committee. Dr. Balzora also serves on the Patient Education Sub-Committee of the Crohn’s and Colitis Foundation (CCF)’s National Scientific Advisory Committee, the social media team of CCF’s Inflammatory Bowel Diseases (IBD) Journal, Fight CRC’s Health Equity Committee, and the Gastroenterology Intersociety Group on Diversity (IGD), comprised of leadership representatives from the four major national gastroenterology societies. She has recently been accepted into the inaugural cohort of the Office of Diversity Affairs’ Faculty Leadership Development Program through the NYU Langone Academy, and is a 2020 recipient of the ACG Presidents Special Recognition Award for efforts in leadership, exemplary service, and guidance promoting diversity, equity, and inclusion. Dr. Balzora currently resides in New York City with her husband and daughter.

Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.

Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.

Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.

Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.

Sandra M. Quezada, MD, MS, received her medical degree from the University of Maryland School of Medicine in Baltimore, where she also completed her post-graduate Residency training in Internal Medicine and Fellowship training in Gastroenterology and Hepatology. She is passionate about Equity, Inclusion, and Diversity, and brings this lens to her work in academic medicine. She is Associate Dean for Medical School Admissions and Associate Dean for Faculty Diversity and Inclusion at the University of Maryland School of Medicine (SOM) and has worked locally, regionally, and nationally to amplify physician workforce diversity and to impact the climate in which future and current physicians train and practice.

Dr. Quezada is a practicing Gastroenterologist who subspecializes in inflammatory bowel disease and is recent past-Chair of the Diversity Committee and current co-Chair of the Equity Task Force for the American Gastroenterological Association (AGA). She is also a member of the Diversity and Inclusion Task Force for the Crohn’s & Colitis Foundation’s National Scientific Advisory, member of the Association of American Medical Colleges Intersectionality Women of Color Workgroup, and Chair of the Intersociety Group on Diversity in Gastroenterology. She is a member of the Alpha Omega Alpha (AOA) National Honor Medical Society, recipient of the Leonard Tow Gold Humanism Award for Humanism in Medicine, and recipient of the AGA Distinguished Award for Diversity, Equity, and Inclusion.

Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.

Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.

Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.

Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.